Park Medi World Q4 Results: Stock gives up initial spurt despite revenue growth, margin expansion

Shares of Park Medi World Ltd. jumped nearly 4% after the company reported a 58% jump in consolidated net profit for the March quarter, as a flurry of acquisitions and new hospital openings powered revenue. The stock, however, gave up all of that initial advance, and is now trading with losses.

Net profit for the March quarter rose to ₹70.9 crore from ₹44.8 crore a year earlier, while consolidated revenue from operations climbed 30% to ₹460.4 crore versus ₹353.9 crore in the year-ago quarter.

Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) expanded 44% to ₹127.3 crore from ₹88.4 crore, with operating margins widening to 27.7% from 24.98%, a 272-basis-point improvement from the base quarter.

Also read:The two major risks that Indian IT stocks face after the latest OpenAI announcement

For FY26, the group reported consolidated revenue from operations of ₹1,679.4 crore and a net profit of ₹273.6 crore, up from ₹215.4 crore in FY25.

The company executed three major acquisitions in quick succession during the second half of the year, including KPS Wellness and Mahip Hospital in January, and SVPD Healthcare in March.

Entities acquired during FY26 collectively contributed ₹25.2 crore to group revenue and a loss before tax of ₹5.6 crore.

The group now consolidates 22 subsidiaries, spanning hospital brands including Aggarwal Hospital, Blue Heavens Healthcare, Park Medicity, Kailash Super-Speciality, and Umkal Healthcare, among others.

Also read: Aurionpro Solutions shares fall 10% as Q4 margins hit multi-year low despite strong FY26 growth

Separately, the board disclosed that Manoj Khanna, the company's Chief Human Resource Officer and a designated Senior Management Personnel, will transition to a regional operational role as Regional Head within the broader Park Group of Hospitals, ceasing to be Senior Management Personnel with immediate effect from May 12, 2026.

Shares of Park Medi World declined by 2%, having cooled off from the day's high, trading 2.2% lower at ₹254.2. The stock is up 22% in the last one month and have risen 70% so far in 2026. The stock is trading well above its IPO price of ₹162 per share.